Pelthos Therapeutics logo

Pelthos Therapeutics

PTHS | AMEX
Chart Builder DCF Calculator
$7.15
-$0.29 (-3.90%)
At close: Nov 16, 2026, 4:00 PM ET
$7.15
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET
-3.90%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
31.2
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #768/1021 (Top 75%)

Key Statistics

Market Data

Market Cap $28.1M
1D Range
7.08 7.81
52W Range
7.08 33.30

Valuation (TTM)

PE -0.38
PB -4.54
EV/EBITDA -1.46

Valuation (NTM)

Forward PE 18.56
Forward PEG -0.23
Price Target $35.00
Loading financial charts...

Profile

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primar...

Sector Healthcare
Industry Biotechnology
Employees 92
IPO Date Feb 16, 2024
Website pelthos.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$2.04
Beat +33.77%
REV
$15.4M
Miss -9.00%
Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$35.00
Upside
+389.51%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.